search
Back to results

Heterologous Effect of Diptheria, Tetanus, Acellular Pertussis Vaccination on Influenza Challenge in the Elderly

Primary Purpose

Heterologous Effects of Vaccines

Status
Unknown status
Phase
Not Applicable
Locations
Australia
Study Type
Interventional
Intervention
Seasonal influenza vaccine
Diphtheria-tetanus-acellular pertussis vaccine
Sponsored by
Clifford Craig Medical Research Trust
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Heterologous Effects of Vaccines

Eligibility Criteria

30 Years - 100 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Two study groups 30-50 years old >65 years old

Exclusion Criteria:

  • Unwell on day of vaccination
  • Temperature >38°C
  • Active cancer
  • Active autoimmune disease
  • Diabetes mellitus
  • Taking immunosuppressive drugs including steroids
  • Any vaccination in last 3 months
  • DT or DTaP vaccination in the last year
  • Known allergy or contraindication to influenza or DTaP vaccination
  • Pregnant or breastfeeding

Sites / Locations

  • Clifford Craig FoundationRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

Active Comparator

Arm Label

Group 1

Group 2

Group 3

Arm Description

Diphtheria-tetanus-acellular pertussis vaccine administered day 0, followed by seasonal influenza vaccination four weeks later. Blood testing to occur day 0 (prior to vaccine administration), 24 hours, 1 week, 4 weeks, 4 weeks + 24 hours, 5 weeks, 8 weeks and 30 weeks. Stool samples to be taken at day 0 and 1 week post-vaccination.

Seasonal influenza vaccine administered on day 0, to be offered DTP vaccine at week 26. Blood testing to occur day 0 (prior to vaccine administration), 24 hours, 1 week 1, 4 weeks and 26 weeks. Stool samples to be taken at day 0 and 1 week post-vaccination.

Seasonal influenza vaccine and DTP vaccine administered together on day 0. Blood testing to occur day 0 (prior to vaccine administration), 24 hours, 1 week 1, 4 weeks and 26 weeks. Stool samples to be taken at day 0 and 1 week post-vaccination.

Outcomes

Primary Outcome Measures

Number of inflammation reactive TNFR2+ regulatory T cells per mL of blood
Change over time in different vaccine groups of Tregs measured by flow cytometry.

Secondary Outcome Measures

Whole human genome transcription profile by next generation sequencing in log2 expression levels
Differential gene expression 24 hours after vaccination compared to baseline, and vaccine groups compared to see which genes / pathways are affected. Differential transcription determined for each gene, then analysed using modular analysis tools to determine vaccine effects.
Influenza-specific antibody titres to seasonal influenza vaccination
Change over time in the different vaccine groups of titres measured by haemagglutination inhibition assay.
Pro-inflammatory (TNF) to anti-inflammatory (IL-10) cytokine ratio in stimulated blood in pg/mL
Change in TNF:IL-10 ratio post-vaccination over time as measured by cytokine multiplex assay of anti-CD3 stimulated PBMC.
Influenza-specific IFN-g CD4 T cell responses to seasonal influenza vaccination in pg/mL
Change over time in the different vaccine groups of IFN-g levels in supernatants from CD4 T cells cultured with live influenza virus

Full Information

First Posted
May 3, 2016
Last Updated
July 25, 2017
Sponsor
Clifford Craig Medical Research Trust
Collaborators
Monash University, The Peter Doherty Institute for Infection and Immunity, University of Sao Paulo, Johns Hopkins Bloomberg School of Public Health
search

1. Study Identification

Unique Protocol Identification Number
NCT02765126
Brief Title
Heterologous Effect of Diptheria, Tetanus, Acellular Pertussis Vaccination on Influenza Challenge in the Elderly
Official Title
Clifford Craig Vaccine Trial Centre: Heterologous Effect of Diptheria, Tetanus, Acellular Pertussis Vaccination on Influenza Vaccine Challenge in the Elderly
Study Type
Interventional

2. Study Status

Record Verification Date
July 2017
Overall Recruitment Status
Unknown status
Study Start Date
May 2016 (undefined)
Primary Completion Date
December 2019 (Anticipated)
Study Completion Date
December 2019 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Clifford Craig Medical Research Trust
Collaborators
Monash University, The Peter Doherty Institute for Infection and Immunity, University of Sao Paulo, Johns Hopkins Bloomberg School of Public Health

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Vaccines can have non-targeted or heterologous (also called non-specific) immunological effects on the immune system i.e. effects other than inducing an immune response against the disease targeted by the vaccine. This trial aims to evaluate the non-specific immunological effects of two vaccines - diphtheria-tetanus-acellular pertussis (DTP) vaccine and seasonal influenza vaccine - in a cohort of elderly humans (>65 years of age) and healthy adult control subjects (30-50 years).
Detailed Description
This prospective randomised study aims to investigate the heterologous immunological effects of DTP and seasonal influenza (Flu) vaccination in an elderly Tasmanian population and healthy adults. The study will assess whether prior or concurrent administration of DTP with seasonal Flu vaccination affects generalised inflammation / immune homeostasis and gene expression, with a particular focus of inflammation reactive cells. It will also analyse for effects of DTP on the induction of vaccine-specific immunity to seasonal influenza vaccination (antibodies and cellular). Volunteers will be randomised to one of three vaccine groups and serial blood samples taken for immunological assays for up to 30 weeks. The study is exploratory and will investigate vaccine effects on multiple immune parameters.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heterologous Effects of Vaccines

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
450 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Group 1
Arm Type
Active Comparator
Arm Description
Diphtheria-tetanus-acellular pertussis vaccine administered day 0, followed by seasonal influenza vaccination four weeks later. Blood testing to occur day 0 (prior to vaccine administration), 24 hours, 1 week, 4 weeks, 4 weeks + 24 hours, 5 weeks, 8 weeks and 30 weeks. Stool samples to be taken at day 0 and 1 week post-vaccination.
Arm Title
Group 2
Arm Type
Active Comparator
Arm Description
Seasonal influenza vaccine administered on day 0, to be offered DTP vaccine at week 26. Blood testing to occur day 0 (prior to vaccine administration), 24 hours, 1 week 1, 4 weeks and 26 weeks. Stool samples to be taken at day 0 and 1 week post-vaccination.
Arm Title
Group 3
Arm Type
Active Comparator
Arm Description
Seasonal influenza vaccine and DTP vaccine administered together on day 0. Blood testing to occur day 0 (prior to vaccine administration), 24 hours, 1 week 1, 4 weeks and 26 weeks. Stool samples to be taken at day 0 and 1 week post-vaccination.
Intervention Type
Biological
Intervention Name(s)
Seasonal influenza vaccine
Other Intervention Name(s)
Quadrivalent Influenza Vaccine
Intervention Description
Intramuscular standard seasonal influenza vaccine
Intervention Type
Biological
Intervention Name(s)
Diphtheria-tetanus-acellular pertussis vaccine
Other Intervention Name(s)
Boostrix vaccine
Intervention Description
Intramuscular DTaP vaccine
Primary Outcome Measure Information:
Title
Number of inflammation reactive TNFR2+ regulatory T cells per mL of blood
Description
Change over time in different vaccine groups of Tregs measured by flow cytometry.
Time Frame
24 hours, 1 week, 4 weeks and 26 weeks
Secondary Outcome Measure Information:
Title
Whole human genome transcription profile by next generation sequencing in log2 expression levels
Description
Differential gene expression 24 hours after vaccination compared to baseline, and vaccine groups compared to see which genes / pathways are affected. Differential transcription determined for each gene, then analysed using modular analysis tools to determine vaccine effects.
Time Frame
24 hours
Title
Influenza-specific antibody titres to seasonal influenza vaccination
Description
Change over time in the different vaccine groups of titres measured by haemagglutination inhibition assay.
Time Frame
4 weeks and 26 weeks
Title
Pro-inflammatory (TNF) to anti-inflammatory (IL-10) cytokine ratio in stimulated blood in pg/mL
Description
Change in TNF:IL-10 ratio post-vaccination over time as measured by cytokine multiplex assay of anti-CD3 stimulated PBMC.
Time Frame
24 hours, 1 week, 4 weeks and 26 weeks
Title
Influenza-specific IFN-g CD4 T cell responses to seasonal influenza vaccination in pg/mL
Description
Change over time in the different vaccine groups of IFN-g levels in supernatants from CD4 T cells cultured with live influenza virus
Time Frame
4 weeks and 26 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Two study groups 30-50 years old >65 years old Exclusion Criteria: Unwell on day of vaccination Temperature >38°C Active cancer Active autoimmune disease Diabetes mellitus Taking immunosuppressive drugs including steroids Any vaccination in last 3 months DT or DTaP vaccination in the last year Known allergy or contraindication to influenza or DTaP vaccination Pregnant or breastfeeding
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Kathryn Ogden, MPH FRACGP
Phone
+61 3 6777 8790
Email
kathryn.ogden@utas.edu.au
First Name & Middle Initial & Last Name or Official Title & Degree
Jane Niekamp
Email
research@cliffordcraig.org.au
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Katie Flanagan, PhD FRACP
Organizational Affiliation
Clifford Craig Medical Research Trust
Official's Role
Principal Investigator
Facility Information:
Facility Name
Clifford Craig Foundation
City
Launceston
State/Province
Tasmania
ZIP/Postal Code
7250
Country
Australia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kathryn Ogden, MBBS, MPH
Phone
03 6777 6010
Email
kathryn.ogden@utas.edu.au
First Name & Middle Initial & Last Name & Degree
Jane Niekamp
Phone
03 6777 6010
First Name & Middle Initial & Last Name & Degree
Katie Flanagan

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
The transcriptome data will be de-identified and deposited in a pubic database. The de-identified microbiome data may well also be made publically available.
Citations:
PubMed Identifier
24864348
Citation
Meeting of the Strategic Advisory Group of Experts on immunization, April 2014 -- conclusions and recommendations. Wkly Epidemiol Rec. 2014 May 23;89(21):221-36. No abstract available. English, French.
Results Reference
background
PubMed Identifier
21118875
Citation
Aaby P, Martins CL, Garly ML, Bale C, Andersen A, Rodrigues A, Ravn H, Lisse IM, Benn CS, Whittle HC. Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial. BMJ. 2010 Nov 30;341:c6495. doi: 10.1136/bmj.c6495.
Results Reference
background
PubMed Identifier
24570246
Citation
Sorup S, Benn CS, Poulsen A, Krause TG, Aaby P, Ravn H. Live vaccine against measles, mumps, and rubella and the risk of hospital admissions for nontargeted infections. JAMA. 2014 Feb 26;311(8):826-35. doi: 10.1001/jama.2014.470.
Results Reference
background
PubMed Identifier
22619263
Citation
Aaby P, Benn C, Nielsen J, Lisse IM, Rodrigues A, Ravn H. Testing the hypothesis that diphtheria-tetanus-pertussis vaccine has negative non-specific and sex-differential effects on child survival in high-mortality countries. BMJ Open. 2012 May 22;2(3):e000707. doi: 10.1136/bmjopen-2011-000707. Print 2012.
Results Reference
background
PubMed Identifier
17914038
Citation
Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med. 2007 Oct 4;357(14):1373-81. doi: 10.1056/NEJMoa070844.
Results Reference
background
PubMed Identifier
16213065
Citation
Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine. 2006 Feb 20;24(8):1159-69. doi: 10.1016/j.vaccine.2005.08.105. Epub 2005 Sep 19.
Results Reference
background
PubMed Identifier
21785218
Citation
Sasaki S, Sullivan M, Narvaez CF, Holmes TH, Furman D, Zheng NY, Nishtala M, Wrammert J, Smith K, James JA, Dekker CL, Davis MM, Wilson PC, Greenberg HB, He XS. Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. J Clin Invest. 2011 Aug;121(8):3109-19. doi: 10.1172/JCI57834. Epub 2011 Jul 25.
Results Reference
background
PubMed Identifier
24579700
Citation
Grant EJ, Chen L, Quinones-Parra S, Pang K, Kedzierska K, Chen W. T-cell immunity to influenza A viruses. Crit Rev Immunol. 2014;34(1):15-39. doi: 10.1615/critrevimmunol.2013010019.
Results Reference
background
PubMed Identifier
12023394
Citation
Saurwein-Teissl M, Lung TL, Marx F, Gschosser C, Asch E, Blasko I, Parson W, Bock G, Schonitzer D, Trannoy E, Grubeck-Loebenstein B. Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol. 2002 Jun 1;168(11):5893-9. doi: 10.4049/jimmunol.168.11.5893.
Results Reference
background
PubMed Identifier
22212127
Citation
Weston WM, Friedland LR, Wu X, Howe B. Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix((R))): results of two randomized trials. Vaccine. 2012 Feb 21;30(9):1721-8. doi: 10.1016/j.vaccine.2011.12.055. Epub 2011 Dec 31.
Results Reference
background
PubMed Identifier
22560929
Citation
Solana R, Tarazona R, Gayoso I, Lesur O, Dupuis G, Fulop T. Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans. Semin Immunol. 2012 Oct;24(5):331-41. doi: 10.1016/j.smim.2012.04.008. Epub 2012 May 4.
Results Reference
background
PubMed Identifier
20100933
Citation
Panda A, Qian F, Mohanty S, van Duin D, Newman FK, Zhang L, Chen S, Towle V, Belshe RB, Fikrig E, Allore HG, Montgomery RR, Shaw AC. Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J Immunol. 2010 Mar 1;184(5):2518-27. doi: 10.4049/jimmunol.0901022. Epub 2010 Jan 25.
Results Reference
background
PubMed Identifier
22388931
Citation
Baylis D, Bartlett DB, Syddall HE, Ntani G, Gale CR, Cooper C, Lord JM, Sayer AA. Immune-endocrine biomarkers as predictors of frailty and mortality: a 10-year longitudinal study in community-dwelling older people. Age (Dordr). 2013 Jun;35(3):963-71. doi: 10.1007/s11357-012-9396-8. Epub 2012 Mar 3.
Results Reference
background
PubMed Identifier
17116321
Citation
Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, Panourgia MP, Invidia L, Celani L, Scurti M, Cevenini E, Castellani GC, Salvioli S. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev. 2007 Jan;128(1):92-105. doi: 10.1016/j.mad.2006.11.016. Epub 2006 Nov 20.
Results Reference
background
PubMed Identifier
12967692
Citation
Bruunsgaard H, Andersen-Ranberg K, Hjelmborg Jv, Pedersen BK, Jeune B. Elevated levels of tumor necrosis factor alpha and mortality in centenarians. Am J Med. 2003 Sep;115(4):278-83. doi: 10.1016/s0002-9343(03)00329-2.
Results Reference
background
PubMed Identifier
22554418
Citation
Nikolich-Zugich J, Li G, Uhrlaub JL, Renkema KR, Smithey MJ. Age-related changes in CD8 T cell homeostasis and immunity to infection. Semin Immunol. 2012 Oct;24(5):356-64. doi: 10.1016/j.smim.2012.04.009. Epub 2012 May 1.
Results Reference
background
PubMed Identifier
25309517
Citation
Ndure J, Flanagan KL. Targeting regulatory T cells to improve vaccine immunogenicity in early life. Front Microbiol. 2014 Sep 11;5:477. doi: 10.3389/fmicb.2014.00477. eCollection 2014.
Results Reference
background
PubMed Identifier
16375694
Citation
Crimeen-Irwin B, Scalzo K, Gloster S, Mottram PL, Plebanski M. Failure of immune homeostasis -- the consequences of under and over reactivity. Curr Drug Targets Immune Endocr Metabol Disord. 2005 Dec;5(4):413-22. doi: 10.2174/156800805774912980.
Results Reference
background
PubMed Identifier
23964278
Citation
Govindaraj C, Scalzo-Inguanti K, Scholzen A, Li S, Plebanski M. TNFR2 Expression on CD25(hi)FOXP3(+) T Cells Induced upon TCR Stimulation of CD4 T Cells Identifies Maximal Cytokine-Producing Effectors. Front Immunol. 2013 Aug 6;4:233. doi: 10.3389/fimmu.2013.00233. eCollection 2013.
Results Reference
background
PubMed Identifier
25705207
Citation
Wilson KL, Xiang SD, Plebanski M. Montanide, Poly I:C and nanoparticle based vaccines promote differential suppressor and effector cell expansion: a study of induction of CD8 T cells to a minimal Plasmodium berghei epitope. Front Microbiol. 2015 Feb 6;6:29. doi: 10.3389/fmicb.2015.00029. eCollection 2015.
Results Reference
background
PubMed Identifier
20525892
Citation
Chen X, Hamano R, Subleski JJ, Hurwitz AA, Howard OM, Oppenheim JJ. Expression of costimulatory TNFR2 induces resistance of CD4+FoxP3- conventional T cells to suppression by CD4+FoxP3+ regulatory T cells. J Immunol. 2010 Jul 1;185(1):174-82. doi: 10.4049/jimmunol.0903548. Epub 2010 Jun 4.
Results Reference
background
PubMed Identifier
23572484
Citation
Flanagan KL, van Crevel R, Curtis N, Shann F, Levy O; Optimmunize Network. Heterologous ("nonspecific") and sex-differential effects of vaccines: epidemiology, clinical trials, and emerging immunologic mechanisms. Clin Infect Dis. 2013 Jul;57(2):283-9. doi: 10.1093/cid/cit209. Epub 2013 Apr 9.
Results Reference
background
PubMed Identifier
22012654
Citation
Nakaya HI, Li S, Pulendran B. Systems vaccinology: learning to compute the behavior of vaccine induced immunity. Wiley Interdiscip Rev Syst Biol Med. 2012 Mar-Apr;4(2):193-205. doi: 10.1002/wsbm.163. Epub 2011 Oct 19.
Results Reference
background
PubMed Identifier
21743478
Citation
Nakaya HI, Wrammert J, Lee EK, Racioppi L, Marie-Kunze S, Haining WN, Means AR, Kasturi SP, Khan N, Li GM, McCausland M, Kanchan V, Kokko KE, Li S, Elbein R, Mehta AK, Aderem A, Subbarao K, Ahmed R, Pulendran B. Systems biology of vaccination for seasonal influenza in humans. Nat Immunol. 2011 Jul 10;12(8):786-95. doi: 10.1038/ni.2067.
Results Reference
background
PubMed Identifier
24367114
Citation
Furman D, Hejblum BP, Simon N, Jojic V, Dekker CL, Thiebaut R, Tibshirani RJ, Davis MM. Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination. Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):869-74. doi: 10.1073/pnas.1321060111. Epub 2013 Dec 23.
Results Reference
background
PubMed Identifier
21565245
Citation
Yao X, Hamilton RG, Weng NP, Xue QL, Bream JH, Li H, Tian J, Yeh SH, Resnick B, Xu X, Walston J, Fried LP, Leng SX. Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in community-dwelling older adults. Vaccine. 2011 Jul 12;29(31):5015-21. doi: 10.1016/j.vaccine.2011.04.077. Epub 2011 May 10.
Results Reference
background
PubMed Identifier
20173391
Citation
Chen X, Oppenheim JJ. TNF-alpha: an activator of CD4+FoxP3+TNFR2+ regulatory T cells. Curr Dir Autoimmun. 2010;11:119-34. doi: 10.1159/000289201. Epub 2010 Feb 18.
Results Reference
background
PubMed Identifier
22903566
Citation
Duraisingham SS, Rouphael N, Cavanagh MM, Nakaya HI, Goronzy JJ, Pulendran B. Systems biology of vaccination in the elderly. Curr Top Microbiol Immunol. 2013;363:117-42. doi: 10.1007/82_2012_250.
Results Reference
background

Learn more about this trial

Heterologous Effect of Diptheria, Tetanus, Acellular Pertussis Vaccination on Influenza Challenge in the Elderly

We'll reach out to this number within 24 hrs